Stock Events

Stock Events

Cartesian Therapeutics (RNAC) Q2 2024 Earnings

8MayConfirmed

Q4 2023

Q2 2024

-10.5

-7.3

-4.09

-0.88

Details

Expected EPS

-0.885

Actual EPS

-10.5

Surprise EPS

-9.62

Surprise Percent

+1,086.44%

Description

Cartesian Therapeutics (RNAC) has reported earnings of -10.5 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.